| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA638343 | A | HPLC capacity factor (k') | 77 | assay format | Scientific Literature | |||
| 2. | ALA694222 | F | Concentration required to inhibit HSV type 1 strain HF induced cytopathogenic affects by 50% | Human alphaherpesvirus 1 | 14 | organism-based format | Scientific Literature | ||
| 3. | ALA877527 | F | In vitro antiviral activity in secondary cultures of rabbit kidney cells infected with HSV type 1 strain HF | Human alphaherpesvirus 1 | 14 | organism-based format | Scientific Literature | ||
| 4. | ALA701748 | F | Compound was tested for its antitumor activity to inhibit 50% of tumor cell growth in mouse leukemia L1210 cell lines. | Mus musculus | 11 | cell-based format | Scientific Literature | ||
| 5. | ALA759252 | F | Compound was tested for its antitumor activity to inhibit 50% of tumor cell growth in mouse leukemia P388 cell lines. | Mus musculus | 11 | cell-based format | Scientific Literature | ||
| 6. | ALA821335 | F | Concentration required to inhibit vaccinia virus induced cytopathogenic affects by 50% | Vaccinia virus | 10 | organism-based format | Scientific Literature | ||
| 7. | ALA821892 | F | In vitro for antiviral activity in secondary cultures of rabbit kidney cells infected with vaccinia virus | Vaccinia virus | 10 | organism-based format | Scientific Literature | ||
| 8. | ALA849749 | B | Molar potency ratio was evaluated | Canis lupus familiaris | 70 | single protein format | Scientific Literature | ||
| 9. | ALA898384 | F | Antimalarial activity against drug-sensitive Plasmodium falciparum 3D7 after 24 hrs | Plasmodium falciparum | 26 | organism-based format | Scientific Literature | ||
| 10. | ALA898385 | F | Antimalarial activity against chloroquine,pyrimethamine-resistant Plasmodium falciparum K1 after 24 hrs | Plasmodium falciparum | 20 | organism-based format | Scientific Literature | ||
| 11. | ALA898386 | F | Antimalarial activity against chloroquine, pyrimethamine and cycloguanil-resistant Plasmodium falciparum VS1 after 24 hrs | Plasmodium falciparum | 26 | organism-based format | Scientific Literature | ||
| 12. | ALA898387 | F | Cytotoxicity against human KB cells | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
| 13. | ALA898388 | F | Selectivity index, ratio of CC50 for human KB cells to IC50 for Plasmodium falciparum 3D7 | 26 | cell-based format | Scientific Literature | |||
| 14. | ALA898389 | F | Selectivity index, ratio of CC50 for human KB cells to IC50 for Plasmodium falciparum K1 | 20 | cell-based format | Scientific Literature | |||
| 15. | ALA898390 | F | Selectivity index, ratio of CC50 for human KB cells to IC50 for Plasmodium falciparum VS1 | 26 | cell-based format | Scientific Literature | |||
| 16. | ALA1794486 | F | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | 10,834 | assay format | PubChem BioAssays | |||
| 17. | ALA1265877 | A | Cytotoxicity against human HeLaS3 cells assessed cell viability at 0.05 after 24 hrs by Alamar blue assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 18. | ALA1265879 | F | Antiviral activity against Poliovirus G64S infected in HeLaS3 cells at 2 mM after 6 hrs | Human enterovirus C | 4 | organism-based format | Scientific Literature | ||
| 19. | ALA1265880 | A | Metabolic stability in human HeLaS3 cells assessed as JA28-triphosphate at 0.5 mM after 2 hrs by reverse-phase HPLC | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 20. | ALA1265881 | F | Antiviral activity against Poliovirus infected in compound pre-treated HeLaS3 cells assessed as reduction in viral titer at 0.5 mM after 6 hrs relative to control | Human enterovirus C | 2 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!